The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
Open Access
- 1 May 1999
- journal article
- duplicate publication
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 103 (9), 1227-1230
- https://doi.org/10.1172/jci6869
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survivalJournal of Clinical Investigation, 1999
- Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonistJournal of Clinical Investigation, 1999
- Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv IntegrinsCell, 1998
- Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during AngiogenesisThe Journal of cell biology, 1998
- Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.Journal of Clinical Investigation, 1996
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Confocal Microscopic Analysis of Integrin Expression on the Microvasculature and its Sprouts in the Neonatal ForeskinJournal of Investigative Dermatology, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.Journal of Clinical Investigation, 1992